News
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.
The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...
Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...
Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.
The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about how geopolitical instability in Europe, and ...
FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.
Amit Chivate, senior market manager, Greater Asia and China, Roquette, provides his perspective on FDA’s recommendations ...
The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the ...
The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for ...
BioPharm International® spoke with Lun Xin, associate director at WuXi Biologics, about high-concentration biologics and some of the biggest challenges associated with their formulation.
The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about how technological advances will impact the biopharma industry in the future.
BioPharm International® sat down with Noah Kopcho, field application scientist at Gyros Protein Technologies, to talk about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results